Tomorrow, we are expecting a big pharma sales rep at our anaesthetic department. He is pushing the α2-agonist Dexmedetomidine. It has been around for a decade but I have no experience with it myself and as far as I know it is only now being introduced in my little part of the world. It is being hyped as the first new intensive care sedative introduced in a decade.
Some of us have been using clonidine for a long time, but dexmedetomidine makes bolder claims. Anyway, before I get on the local bandwagon I’ll be reading this:
(Well, I intend to.)